fbpx

AdBlock Detected

It looks like you're using an ad-blocker!

Our team work realy hard to produce quality content on this website and we noticed you have ad-blocking enabled.

Skip to content
Purelyfitliving
  • Home
  • Weight loss
  • Food Recipes
  • Health Insurance
  • Health And Wellness
  • Diseases and Treatment
  • Home
  • Weight loss
  • Food Recipes
  • Health Insurance
  • Health And Wellness
  • Diseases and Treatment
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • Blog
  • HIV
Recent Studies on HIV Treatments and Patient-Reported Outcomes
Posted inDiseases and Treatment

Recent Studies on HIV Treatments and Patient-Reported Outcomes

An expert on HIV discusses recent real-world studies and research on patient-reported outcomes, detailing treatment algorithms under investigation and their reported tolerability. Source link
Read More
Differences in Binding Affinity Between Integrase Inhibitors in HIV
Posted inDiseases and Treatment

Differences in Binding Affinity Between Integrase Inhibitors in HIV

An infectious disease specialist discusses the differences in binding affinity between dolutegravir and bictegravir and how it informs treatment selection. Source link
Read More
Restarting Therapy in Patients with HIV
Posted inDiseases and Treatment

Restarting Therapy in Patients with HIV

Addressing patients with HIV who have fallen out of care, Shauna Applin, ARNP, provides clinical insights on treatment options and best practices for restarting therapy. Source link
Read More
Switching Therapies in HIV
Posted inDiseases and Treatment

Switching Therapies in HIV

An expert on HIV provides clinical insights on the rationale for switching therapies and ways to educate patients on treatment decisions. Source link
Read More
Switching Therapies for Patients with HIV and History of Resistance
Posted inDiseases and Treatment

Switching Therapies for Patients with HIV and History of Resistance

Experts on HIV offer insights into switching therapies for patients with a history of resistance, highlighting ways to simplify and optimize treatment. Source link
Read More
Resources Available for Patients with HIV Drug Resistance
Posted inDiseases and Treatment

Resources Available for Patients with HIV Drug Resistance

The panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance. Source link
Read More
HIV Treatment Clinical Experiences
Posted inDiseases and Treatment

HIV Treatment Clinical Experiences

Focusing on the management of patients with HIV, the panel provides clinical insights on treatment selection, focusing on long-acting agents. Source link
Read More
Addressing Suboptimal Treatment Response in HIV
Posted inDiseases and Treatment

Addressing Suboptimal Treatment Response in HIV

A panel of experts on HIV discuss decision-making practices for patients who have suboptimal response to their current treatment regimen. Source link
Read More
The Role of the Primary Care Provider/Advanced Practice Provider in HIV Management
Posted inDiseases and Treatment

The Role of the Primary Care Provider/Advanced Practice Provider in HIV Management

A panel of experts on HIV open the discussion with a conversation about the role of the primary care provider and advanced practice provider in treating patients with HIV. Source…
Read More
Evolving Treatment Practices and Guidelines for HIV
Posted inDiseases and Treatment

Evolving Treatment Practices and Guidelines for HIV

Focusing on the evolving treatment paradigms for HIV, the panel reviews guideline recommendations for initial therapy and discusses education practices for newly diagnosed patients. Source link
Read More

Posts pagination

1 2 Next page
Ads

Recent Posts

  • Cinnamon Pull-Apart Bread | The Recipe Critic
  • The Slow-Moving Antimicrobial Resistance Train is Picking-up Morbidity and Mortality Steam
  • Christmas Dinner Menu Plan | The Recipe Critic
  • The Dangers of Coconut Oil Pulling
  • Gilead Submits FDA New Drug Application for Lenacapavir for HIV Prevention
Ads
Enter Tweet Content here... Click to Tweet
Scroll to Top
Add new entry logo

This website uses cookies to improve your experience. We\'ll assume you\'re ok with this, but you can opt-out if you wish. Read More

I consent to the use of following cookies:
Cookie Declaration About Cookies
Necessary (0) Marketing (0) Analytics (0) Preferences (0) Unclassified (0)
Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
We do not use cookies of this type.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
We do not use cookies of this type.
Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
We do not use cookies of this type.
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
We do not use cookies of this type.
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
We do not use cookies of this type.
Cookies are small text files that can be used by websites to make a user\'s experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
Cookie Settings

Daily Dose of Insights

Get a daily infusion of knowledge with our latest blog updates.

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.